Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brodie M. J., McIntosh M. E., Hallworth M. Therapeutic drug monitoring--the need for audit? Scott Med J. 1985 Apr;30(2):75–82. doi: 10.1177/003693308503000202. [DOI] [PubMed] [Google Scholar]
- Brodie M. J. Therapeutic drug monitoring. Practitioner. 1986 Nov;230(1421):1003–1009. [PubMed] [Google Scholar]
- Callaghan N., Kenny R. A., O'Neill B., Crowley M., Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry. 1985 Jul;48(7):639–644. doi: 10.1136/jnnp.48.7.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feldman R. G., Pippenger C. E. The relation of anticonvulsant drug levels to complete seizure control. J Clin Pharmacol. 1976 Jan;16(1):51–59. doi: 10.1002/j.1552-4604.1976.tb01491.x. [DOI] [PubMed] [Google Scholar]
- Gannaway D. J., Mawer G. E. Serum phenytoin concentration and clinical response in patients with epilepsy. Br J Clin Pharmacol. 1981 Dec;12(6):833–839. doi: 10.1111/j.1365-2125.1981.tb01316.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shorvon S. D., Chadwick D., Galbraith A. W., Reynolds E. H. One drug for epilepsy. Br Med J. 1978 Feb 25;1(6111):474–476. doi: 10.1136/bmj.1.6111.474. [DOI] [PMC free article] [PubMed] [Google Scholar]